CN1085085C - Chinese drug for curing rheumatism and its producing technology - Google Patents
Chinese drug for curing rheumatism and its producing technology Download PDFInfo
- Publication number
- CN1085085C CN1085085C CN97114484A CN97114484A CN1085085C CN 1085085 C CN1085085 C CN 1085085C CN 97114484 A CN97114484 A CN 97114484A CN 97114484 A CN97114484 A CN 97114484A CN 1085085 C CN1085085 C CN 1085085C
- Authority
- CN
- China
- Prior art keywords
- chinese medicine
- parts
- rheumatism
- treating
- centipedes
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The present invention relates to a Chinese medicine for treating rheumatism, which has the preparing method that centipedes, tripterygium hypoglaucum hutch, giant typhonium herb, eupolyphaga, Chinese hydrangeavine root-bark, sinomenium acutum, astragalus roots, rhododendron molle, mistletoe, Chinese wolfberry and licorice roots are used as components, the Chinese medicines except the giant typhonium herb and the centipedes are soaked by ethanol, the dregs of decoction are removed, the ethanol is concentrated into paste after a reflux process, the processes of drying and pulverizing are carried out, the giant typhonium herb and the centipedes are pulverized after the giant typhonium herb and the centipedes are dried, and then the obtained objects after the process of pulverizing are uniformly mixed to obtain the Chinese medicine for treating rheumatism. The Chinese medicine for treating rheumatism can effectively enable tendons to relax, activate blood circulation, eliminate dampness, expel blood stasis, remove toxicity for detumescence and alleviate pain, and therefore, the Chinese medicine can achieve the purpose for thoroughly radically treating the rheumatism. After the Chinese medicine for treating rheumatism is taken for two weeks, the effective rate of the Chinese medicine reaches 97%, the healing rate of the Chinese medicine reaches 94.8% after 2 to 3 courses of treatment, and the Chinese medicine for treating rheumatism has significant treating effect on rheumatic headache, puerperal convulsion, ordinary rheumatic arthritis and hyperostosis painful swelling phenomenon according to the cases of 2 years without recurrence.
Description
The present invention relates to rheumatismal Chinese medicine of a kind of treatment and processing technology thereof.
Rheumatism, rheumatoid arthritis, hyperosteogeny swell and ache, rheumatism headache, puerperal exposure to wind are a kind of commonly encountered diseases, adopt the hormonal medicaments treatment for many years always, side effect is big, although Chinese patent medicine development in recent years rapidly, because prescription is single, limitation is big, does not have so have the medicine that effects a radical cure curative effect fully, and many medicinal backs relapse rate is higher.
The purpose of this invention is to provide a kind of rheumatismal Chinese medicine of treatment and processing technology thereof of rheumatism thoroughly being effected a radical cure, do not have the recurrence appearance.
The object of the present invention is achieved like this: the rheumatismal Chinese medicine of a kind of treatment, it is characterized in that it is prepared from as follows by following bulk drugs thing: the weight with 100 parts of Scolopendras is quota, whenever the Scolopendra that contains 100 parts of weight, other material medicine and content are as follows:
Tripterygium hypoglaucum 300-500 part
Herba Typhonii gigantei 1000-2000 part
worm 100-150 part
Cortex schizophragmatis integrifolii radicis 300-400 part
Radix Stephaniae Tetrandrae 300-400 part
Radix Astragali 600-800 part
Flos Rhododendri Mollis 400-500 part
Herba Taxilli 200-350 part
Fructus Lycii 300-400 part
Radix Glycyrrhizae 200-300 part
Treat the processing technology of rheumatismal Chinese medicine, pass through following steps successively:
(1), will remove medicinal residues and filter with soak with ethanol 48 hours except that other Chinese medicine washing of Herba Typhonii gigantei and Scolopendra is clean, behind alcohol reflux, be condensed into paste, drying and crushing to 100 order,
(2), with the Herba Typhonii gigantei chip drying, after the Scolopendra drying, the two is crushed to 100 order powder, then the powder mixing of gained powder and the 1st step is promptly made Chinese medicine of the present invention.
The present invention can realize relaxing muscles and tendons to promote blood circulation effectively, the damp eliminating blood stasis dispelling, and reducing swelling and alleviating pain reaches the rheumatismal purpose of thorough radical cure.The present invention is from nineteen ninety-five applying clinical totally 180 examples, and the general every day three times of taking medicine, each 6-8 grain (every 0.2 gram) is taken medicine and taken effect in back 3 days, and after two weeks of medication, effective percentage reaches 97%, two to three courses of treatment of medication (be a course of treatment every month).Cure rate reaches 94.8%, and through two winters, observe two rainy seasons, and no recurrent cases can achieve the goal to rheumatism headache, puerperal exposure to wind and general rheumatic arthritis medication a course of treatment, and hyperosteogeny is swollen and ache has the effect of obvious reducing swelling and alleviating pain.Clinical model case has:
Liu Dehui: the man, 47 years old, Xiuyan, county, Xiuyan, Liaoning Province people from town suffered from rheumatoid disease 16 years, need lean on crutch in rainy season, winter and walk, swell and ache unbearably, keep by tablet for alleviating pain, meticorten throughout the year, medication was cured after two months, can be engaged in various weight physical works, nothing recurrence in 2 years.
Guan Xiufang: the woman, 52 years old, huge rock people from county in Jilin suffered from rheumatoid bed 4 years, and medication can be leant on cane and walk down after one month, continued medication one month, threw away crutch and can be engaged in various housework, nothing recurrence in 2 years.
Zhou Yanhua: the woman, 44 years old, Liaoning Qing Yuanxian people suffered from rheumatoid 7 years, and one to the overcast and rainy road of not walking, and cures behind two first quarter moons of medication.
Li Zhongfang: the man, 61 years old, lumbar vertebra hyperosteogeny was suffered from by east wind chemical plant, Liaoning retired employees, does not directly play waist, two lower limb edema, pain is heavier, and medication is after one month, and pain, edema disappear.
Above-mentioned case is all by image check, and the periosteum inflammation disappears, bone density strengthens.
Be described in detail technical solution of the present invention below.
Embodiment 1:
Material medicine of the present invention following (weight quota): the weight with 100 parts of Scolopendras is quota, whenever contains the Scolopendra of 100 parts of weight, and other material medicine and content are as follows:
300 parts of Tripterygium hypoglaucumes
1000 parts of Herba Typhonii gigantei
100 parts of worms
300 parts of Cortex schizophragmatis integrifolii radiciss
300 parts of Radix Stephaniae Tetrandrae
600 parts of the Radixs Astragali
400 parts of Flos Rhododendri Mollis
200 parts of Herba Taxillis
300 parts of Fructus Lyciis
200 parts in Radix Glycyrrhizae
Processing technology of the present invention is passed through following steps successively:
1, will remove medicinal residues and filter except that clean soak with ethanol 48 hours of using of other Chinese medicine washing of Herba Typhonii gigantei and Scolopendra, behind alcohol reflux, be condensed into paste, drying and crushing to 100 order,
2, with the Herba Typhonii gigantei chip drying, after the Scolopendra drying, the two is crushed to 100 order powder, then the powder mixing of gained powder and the 1st step is promptly made Chinese medicine of the present invention.
Embodiment 2:
Material medicine of the present invention following (weight quota): the weight with 100 parts of Scolopendras is quota, whenever contains the Scolopendra of 100 parts of weight, and other material medicine and content are as follows:
500 parts of Tripterygium hypoglaucumes
2000 parts of Herba Typhonii gigantei
150 parts of worms
400 parts of Cortex schizophragmatis integrifolii radiciss
400 parts of Radix Stephaniae Tetrandrae
800 parts of the Radixs Astragali
500 parts of Flos Rhododendri Mollis
350 parts of Herba Taxillis
400 parts of Fructus Lyciis
300 parts in Radix Glycyrrhizae
Processing technology of the present invention is passed through following steps successively:
1, will remove medicinal residues and filter except that clean soak with ethanol 48 hours of using of other Chinese medicine washing of Herba Typhonii gigantei and Scolopendra, behind alcohol reflux, be condensed into paste, drying and crushing to 100 order,
2, with the Herba Typhonii gigantei chip drying, after the Scolopendra drying, the two is crushed to 100 order powder, then the powder mixing of gained powder and the 1st step is promptly made Chinese medicine of the present invention.
Embodiment 3:
Material medicine of the present invention following (weight quota): the weight with 100 parts of Scolopendras is quota, whenever contains the Scolopendra of 100 parts of weight, and other material medicine and content are as follows:
400 parts of Tripterygium hypoglaucumes
1500 parts of Herba Typhonii gigantei
120 parts of worms
350 parts of Cortex schizophragmatis integrifolii radiciss
350 parts of Radix Stephaniae Tetrandrae
700 parts of the Radixs Astragali
450 parts of Flos Rhododendri Mollis
300 parts of Herba Taxillis
350 parts of Fructus Lyciis
250 parts in Radix Glycyrrhizae
Processing technology of the present invention is passed through following steps successively:
1, will remove medicinal residues and filter except that clean soak with ethanol 48 hours of using of other Chinese medicine washing of Herba Typhonii gigantei and Scolopendra, behind alcohol reflux, be condensed into paste, drying and crushing to 100 order,
2, with the Herba Typhonii gigantei chip drying, after the Scolopendra drying, the two is crushed to 100 order powder, then the powder mixing of gained powder and the 1st step is promptly made Chinese medicine of the present invention.
Claims (1)
1, the rheumatismal Chinese medicine of a kind of treatment, it is characterized in that it is prepared from as follows by following bulk drugs thing: the weight with 100 parts of Scolopendras is quota, whenever contains the Scolopendra of 100 parts of weight, and other material medicine and content are as follows:
Tripterygium hypoglaucum 300-500 part
Herba Typhonii gigantei 1000-2000 part
worm 100-150 part
Cortex schizophragmatis integrifolii radicis 300-400 part
Radix Stephaniae Tetrandrae 300-400 part
Radix Astragali 600-800 part
Flos Rhododendri Mollis 400-500 part
Herba Taxilli 200-350 part
Fructus Lycii 300-400 part
Radix Glycyrrhizae 200-300 part
Treat the processing technology of rheumatismal Chinese medicine, pass through following steps successively:
(1), will remove medicinal residues and filter with soak with ethanol 48 hours except that other Chinese medicine washing of Herba Typhonii gigantei and Scolopendra is clean, behind alcohol reflux, be condensed into paste, drying and crushing to 100 order,
(2), with the Herba Typhonii gigantei chip drying, after the Scolopendra drying, the two is crushed to 100 order powder, then the powder mixing of gained powder and the 1st step is promptly made Chinese medicine of the present invention.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN97114484A CN1085085C (en) | 1997-08-28 | 1997-08-28 | Chinese drug for curing rheumatism and its producing technology |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN97114484A CN1085085C (en) | 1997-08-28 | 1997-08-28 | Chinese drug for curing rheumatism and its producing technology |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1178697A CN1178697A (en) | 1998-04-15 |
| CN1085085C true CN1085085C (en) | 2002-05-22 |
Family
ID=5172984
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN97114484A Expired - Fee Related CN1085085C (en) | 1997-08-28 | 1997-08-28 | Chinese drug for curing rheumatism and its producing technology |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1085085C (en) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8003139B2 (en) | 2002-04-09 | 2011-08-23 | Sichuan Institute Of Chinese Materia Medica | Pharmaceutical composition for treating rheumatism, and method of making same |
| EP1510217B1 (en) * | 2002-04-09 | 2015-11-11 | Sichuan Institute of Chinese Materia Medica | An anti-rheumatism medicament and method for its preparation |
| CN103933351A (en) * | 2014-04-16 | 2014-07-23 | 李国宣 | Traditional Chinese medicine composition for treating rheumatoid and preparation method thereof |
-
1997
- 1997-08-28 CN CN97114484A patent/CN1085085C/en not_active Expired - Fee Related
Non-Patent Citations (4)
| Title |
|---|
| 《河北医药》1992,14(3) 1992.3.30 王正玉等/昆明山法律顾问棠治疗类风湿性关节炎疗效观察 * |
| 《河北省秦黄岛市第三医院》1997,19(5) 1997.5.30 罗占君等/肖痹灵系列治疗类风湿性关节炎40例疗效观察 * |
| 《河北省秦黄岛市第三医院》1997,19(5) 1997.5.30 罗占君等/肖痹灵系列治疗类风湿性关节炎40例疗效观察;《河北医药》1992,14(3) 1992.3.30 王正玉等/昆明山法律顾问棠治疗类风湿性关节炎疗效观察;《湖北中医杂志》1995,17(6) 1995.6.30 张源芳等/蝎散治疗类风湿性关节炎临床观察 * |
| 《湖北中医杂志》1995,17(6) 1995.6.30 张源芳等/蝎散治疗类风湿性关节炎临床观察 * |
Also Published As
| Publication number | Publication date |
|---|---|
| CN1178697A (en) | 1998-04-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN1695694A (en) | Chinese traditional medicine for treating breast disease and preparing technique | |
| CN1899535A (en) | Method for preparing dermopathic blood toxic capsule | |
| CN1095674C (en) | Chinese medicinal composition for cerebrovascular disease, rheumatism and rheumatoid disease | |
| CN1085085C (en) | Chinese drug for curing rheumatism and its producing technology | |
| CN1124156C (en) | Chinese-medicinal pills for treating rheumatism and preparing process thereof | |
| CN1861155A (en) | Method for preparing traditional Chinese medicine for treating rheumatism and rheumatoid disease, and said medicine thereby | |
| CN1054773C (en) | Chinese patent drug "Bizhengning" for treatment of arthralgia-syndrome | |
| CN1927279A (en) | Chinese medicine composition for treating skin disease | |
| CN1317315A (en) | Tendon-comfortable analgesic | |
| CN1931277A (en) | Osteoarthrosis treating Chinese medicine composition and its prepn process | |
| CN1074676C (en) | Medicine for treating rheumatic arthritis and hyperosteogeny and preparing process thereof | |
| CN1600356A (en) | Combination of Chinese traditional medicine for curing chronic pharyngitis and preparation method | |
| CN1196491C (en) | Ointment for healing tranumatic injury fast | |
| CN1141114C (en) | Tendon-conditioning analgetic | |
| CN1296078C (en) | Chinese medicinal preparation for treating cardiovascular and cerebrovascular disease | |
| CN1377672A (en) | Rheumatic pain killing preparation | |
| CN1063650C (en) | Chinese medicinal pill for curing rheumatism and rheumatoid disease and its preparation method | |
| CN1772054A (en) | Liver softening plaster and its prepn | |
| CN1424094A (en) | Detumescence plaster | |
| CN100336547C (en) | Medicine for treating high blood pressure disease | |
| CN1709434A (en) | Chinese medicine formulation for treating sphagitis | |
| CN1698863A (en) | Chinese medicine preparation for treating hyperosteogeny | |
| CN1172701C (en) | Medicine for curing herpes zoster | |
| CN1122520C (en) | Osteanaphysis capsule for treating femoral head necrosis | |
| CN1058189C (en) | External- and thermal-mounted trauma medicinal powder bag |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C19 | Lapse of patent right due to non-payment of the annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |